Overview of selected clinical fractionation schemes that have been tested in the simulation.

For better comparison of effects the integral dose for all runs has been chosen to be 60 Gy (except for CHART treatment with 54 Gy). In order to test the results of hypo- and hyperfractionation, extreme cases with doubled or halved doses per fraction where chosen. A visualisation of the according fractionation timings is presented in figure 4.